Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 76 - 80 of 121 results Translational Pharmaceutics, Dr. Peter ScholesDoes partnering with a fully integrated services provider really improve your molecule’s chances of clinical and commercial success?Translational Pharmaceutics, Dr. Peter ScholesDoes partnering with a fully integrated services provider really improve your molecule’s chances of clinical and commercial success?Learn more Translational Pharmaceutics, Dr. Aruna Railkar, Solubility Enhancement, CRDMOHow an integrated CRDMO can accelerate the development of complex drug programsTranslational Pharmaceutics, Dr. Aruna Railkar, Solubility Enhancement, CRDMOHow an integrated CRDMO can accelerate the development of complex drug programsLearn more Drug Substance, Translational PharmaceuticsSmall Molecule Drug Substance Development – Part 3: Once your drug substance has been manufactured, how do you successfully bridge into drug product development?Drug Substance, Translational PharmaceuticsSmall Molecule Drug Substance Development – Part 3: Once your drug substance has been manufactured, how do you successfully bridge into drug product development?Learn more Drug Substance, Translational PharmaceuticsSmall Molecule Drug Substance Development - Part 2: How do you streamline manufacturing of your drug substance?Drug Substance, Translational PharmaceuticsSmall Molecule Drug Substance Development - Part 2: How do you streamline manufacturing of your drug substance?Learn more Drug Substance, Translational PharmaceuticsSmall Molecule Drug Substance Development – Part 1: How do you design a safe and scalable synthetic route for your drug substance?Drug Substance, Translational PharmaceuticsSmall Molecule Drug Substance Development – Part 1: How do you design a safe and scalable synthetic route for your drug substance?Learn more Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Page 18 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
